| 0 |
BONE SCAN ABNORMAL |
14 |
0.0329 |
| 1 |
VESSEL PUNCTURE SITE INFLAMMATION |
1 |
0.0256 |
| 2 |
RADIATION OVERDOSE |
1 |
0.0185 |
| 3 |
UVULITIS |
1 |
0.0097 |
| 4 |
RADIOISOTOPE SCAN ABNORMAL |
6 |
0.0085 |
| 5 |
PRODUCT STERILITY ISSUE |
1 |
0.0081 |
| 6 |
IIIRD NERVE DISORDER |
1 |
0.0070 |
| 7 |
BULLOUS HAEMORRHAGIC DERMATOSIS |
1 |
0.0048 |
| 8 |
INJECTION SITE THROMBOSIS |
1 |
0.0030 |
| 9 |
INJECTION SITE CELLULITIS |
5 |
0.0027 |
| 10 |
PRODUCT LABEL ON WRONG PRODUCT |
1 |
0.0025 |
| 11 |
LYMPHATIC DISORDER |
1 |
0.0017 |
| 12 |
PNEUMONIA MYCOPLASMAL |
1 |
0.0013 |
| 13 |
NON-CARDIOGENIC PULMONARY OEDEMA |
1 |
0.0009 |
| 14 |
PRODUCT PREPARATION ISSUE |
6 |
0.0009 |
| 15 |
CONTRAST MEDIA REACTION |
2 |
0.0008 |
| 16 |
TESTICULAR SWELLING |
1 |
0.0008 |
| 17 |
COMPLEX REGIONAL PAIN SYNDROME |
1 |
0.0007 |
| 18 |
AXILLARY PAIN |
1 |
0.0007 |
| 19 |
PHARYNGEAL PARAESTHESIA |
1 |
0.0006 |
| 20 |
SKULL FRACTURE |
1 |
0.0006 |
| 21 |
INJECTION SITE ATROPHY |
1 |
0.0006 |
| 22 |
SEIZURE LIKE PHENOMENA |
1 |
0.0006 |
| 23 |
INJECTION SITE EXTRAVASATION |
7 |
0.0006 |
| 24 |
DRUG MONITORING PROCEDURE NOT PERFORMED |
1 |
0.0006 |
| 25 |
POOR QUALITY PRODUCT ADMINISTERED |
5 |
0.0005 |
| 26 |
PULSE ABSENT |
2 |
0.0004 |
| 27 |
VOMITING PROJECTILE |
1 |
0.0003 |
| 28 |
TESTICULAR PAIN |
1 |
0.0003 |
| 29 |
PRODUCT ADMINISTRATION ERROR |
6 |
0.0003 |
| 30 |
TONGUE OEDEMA |
1 |
0.0003 |
| 31 |
SENSATION OF HEAVINESS |
1 |
0.0003 |
| 32 |
EXTRAVASATION |
1 |
0.0002 |
| 33 |
ANAPHYLACTOID REACTION |
1 |
0.0002 |
| 34 |
STAPHYLOCOCCAL BACTERAEMIA |
1 |
0.0002 |
| 35 |
WRONG DRUG ADMINISTERED |
2 |
0.0002 |
| 36 |
PHLEBITIS |
1 |
0.0002 |
| 37 |
PETECHIAE |
2 |
0.0002 |
| 38 |
CHEILITIS |
1 |
0.0002 |
| 39 |
GENERALISED ERYTHEMA |
1 |
0.0002 |
| 40 |
URINE ODOUR ABNORMAL |
1 |
0.0002 |
| 41 |
LARYNGEAL OEDEMA |
1 |
0.0002 |
| 42 |
VISUAL FIELD DEFECT |
1 |
0.0001 |
| 43 |
TONGUE DISORDER |
1 |
0.0001 |
| 44 |
RASH MACULO-PAPULAR |
3 |
0.0001 |
| 45 |
PHARYNGEAL OEDEMA |
2 |
0.0001 |
| 46 |
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS |
1 |
0.0001 |
| 47 |
SENSORY LOSS |
1 |
0.0001 |
| 48 |
GENERALISED TONIC-CLONIC SEIZURE |
2 |
0.0001 |
| 49 |
RESPIRATORY ARREST |
3 |
0.0001 |
| 50 |
ABORTION INDUCED |
1 |
0.0001 |
| 51 |
INJECTION SITE SWELLING |
8 |
0.0001 |
| 52 |
INJECTION SITE WARMTH |
2 |
0.0001 |
| 53 |
PRURITUS GENERALISED |
2 |
0.0001 |
| 54 |
PRODUCT DISPENSING ERROR |
2 |
0.0001 |
| 55 |
INJECTION SITE DISCOLOURATION |
1 |
0.0001 |
| 56 |
DERMATITIS ALLERGIC |
1 |
0.0001 |
| 57 |
MYDRIASIS |
1 |
0.0001 |
| 58 |
DYSMENORRHOEA |
1 |
0.0001 |
| 59 |
FEELING COLD |
2 |
0.0001 |
| 60 |
DYSGEUSIA |
5 |
0.0001 |
| 61 |
BRAIN FOG |
1 |
0.0001 |
| 62 |
PHOTOSENSITIVITY REACTION |
1 |
0.0001 |
| 63 |
BURNING SENSATION |
4 |
0.0001 |
| 64 |
COLD SWEAT |
1 |
0.0001 |
| 65 |
HEAD DISCOMFORT |
1 |
0.0001 |
| 66 |
INJECTION SITE ERYTHEMA |
7 |
0.0001 |
| 67 |
SYNCOPE |
5 |
0.0000 |
| 68 |
SPINAL FRACTURE |
1 |
0.0000 |
| 69 |
ANGIOEDEMA |
2 |
0.0000 |
| 70 |
GLOSSODYNIA |
1 |
0.0000 |
| 71 |
OCULAR HYPERAEMIA |
2 |
0.0000 |
| 72 |
CELLULITIS |
2 |
0.0000 |
| 73 |
FLUSHING |
4 |
0.0000 |
| 74 |
LOSS OF CONSCIOUSNESS |
5 |
0.0000 |
| 75 |
ERECTILE DYSFUNCTION |
1 |
0.0000 |
| 76 |
ANAPHYLACTIC SHOCK |
1 |
0.0000 |
| 77 |
UNRESPONSIVE TO STIMULI |
1 |
0.0000 |
| 78 |
PHARMACEUTICAL PRODUCT COMPLAINT |
1 |
0.0000 |
| 79 |
MEDICATION ERROR |
2 |
0.0000 |
| 80 |
EYE PAIN |
2 |
0.0000 |
| 81 |
BONE PAIN |
2 |
0.0000 |
| 82 |
LACRIMATION INCREASED |
1 |
0.0000 |
| 83 |
EPILEPSY |
1 |
0.0000 |
| 84 |
FEELING HOT |
2 |
0.0000 |
| 85 |
INJECTION SITE PAIN |
10 |
0.0000 |
| 86 |
LIMB DISCOMFORT |
1 |
0.0000 |
| 87 |
EXPOSURE DURING PREGNANCY |
2 |
0.0000 |
| 88 |
METABOLIC ACIDOSIS |
1 |
0.0000 |
| 89 |
BLOOD PRESSURE DECREASED |
2 |
0.0000 |
| 90 |
URTICARIA |
5 |
0.0000 |
| 91 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
1 |
0.0000 |
| 92 |
INJECTION SITE MASS |
1 |
0.0000 |
| 93 |
CHEST PAIN |
5 |
0.0000 |
| 94 |
EYE SWELLING |
1 |
0.0000 |
| 95 |
CHILLS |
3 |
0.0000 |
| 96 |
DISORIENTATION |
1 |
0.0000 |
| 97 |
BLINDNESS |
1 |
0.0000 |
| 98 |
CARDIAC ARREST |
2 |
0.0000 |
| 99 |
RHABDOMYOLYSIS |
1 |
0.0000 |
| 100 |
HYPERHIDROSIS |
3 |
0.0000 |
| 101 |
VAGINAL HAEMORRHAGE |
1 |
0.0000 |
| 102 |
SEPTIC SHOCK |
1 |
0.0000 |
| 103 |
TACHYCARDIA |
2 |
0.0000 |
| 104 |
PULMONARY OEDEMA |
1 |
0.0000 |
| 105 |
ARRHYTHMIA |
1 |
0.0000 |
| 106 |
RASH ERYTHEMATOUS |
1 |
0.0000 |
| 107 |
NAUSEA |
16 |
0.0000 |
| 108 |
HYPOAESTHESIA |
3 |
0.0000 |
| 109 |
DRUG INTERACTION |
3 |
0.0000 |
| 110 |
THROMBOCYTOPENIA |
2 |
0.0000 |
| 111 |
BLISTER |
1 |
0.0000 |
| 112 |
OXYGEN SATURATION DECREASED |
1 |
0.0000 |
| 113 |
LETHARGY |
1 |
0.0000 |
| 114 |
SEIZURE |
2 |
0.0000 |
| 115 |
ABDOMINAL PAIN |
4 |
0.0000 |
| 116 |
VERTIGO |
1 |
0.0000 |
| 117 |
INFUSION RELATED REACTION |
1 |
0.0000 |
| 118 |
HEADACHE |
9 |
0.0000 |
| 119 |
SKIN BURNING SENSATION |
1 |
0.0000 |
| 120 |
HOT FLUSH |
1 |
0.0000 |
| 121 |
VOMITING |
6 |
0.0000 |
| 122 |
PARAESTHESIA |
2 |
0.0000 |
| 123 |
INJECTION SITE BRUISING |
1 |
0.0000 |
| 124 |
TREMOR |
2 |
0.0000 |
| 125 |
DIZZINESS |
6 |
0.0000 |
| 126 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 127 |
HYPERSENSITIVITY |
2 |
0.0000 |
| 128 |
HYPOTENSION |
2 |
0.0000 |
| 129 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 130 |
ASTHMA |
1 |
0.0000 |
| 131 |
MUSCULAR WEAKNESS |
1 |
0.0000 |
| 132 |
BACK PAIN |
2 |
0.0000 |
| 133 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 134 |
ASTHENIA |
3 |
0.0000 |
| 135 |
PRURITUS |
3 |
0.0000 |
| 136 |
ARTHRALGIA |
3 |
0.0000 |
| 137 |
ANXIETY |
2 |
0.0000 |
| 138 |
RASH |
3 |
0.0000 |
| 139 |
DRUG INEFFECTIVE |
9 |
0.0000 |
| 140 |
PAIN IN EXTREMITY |
2 |
0.0000 |
| 141 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 142 |
FALL |
2 |
0.0000 |
| 143 |
ABDOMINAL DISCOMFORT |
1 |
0.0000 |
| 144 |
NO ADVERSE EVENT |
1 |
0.0000 |
| 145 |
DYSPNOEA |
3 |
0.0000 |
| 146 |
SOMNOLENCE |
1 |
0.0000 |
| 147 |
HYPERTENSION |
1 |
0.0000 |
| 148 |
MALAISE |
2 |
0.0000 |
| 149 |
FEELING ABNORMAL |
1 |
0.0000 |
| 150 |
INSOMNIA |
1 |
0.0000 |
| 151 |
PAIN |
2 |
0.0000 |
| 152 |
DIARRHOEA |
2 |
0.0000 |
| 153 |
PYREXIA |
1 |
0.0000 |
| 154 |
FATIGUE |
2 |
0.0000 |
| 155 |
OFF LABEL USE |
2 |
0.0000 |